when to treat
how to treat
when  damage to  the  optic  nerve  has  been  demonstrated in  the  form  of progressive pathologic cupping and/or characteristic visual field defects
when IOP is elevated to an extent that it is likely to cause damage to the optic nerve.
To preserve visual function by lowering IOP below a level that is likely to produce further damage to the nerve.
The treatment regimen should have lowest risk, fewest side effects, and least disruption of the patient’s life
Should actually be a range with an upper IOP limit that is unlikely to lead to further damage of the nerve in a given patient
The more advanced the<unk> tous process on initial presentation, the lower the target pressure generally needs to be prevent further progression.
An initial reduction in the IOP of 20%-30% from baseline is suggested, but those patients who have progressive NTG may require a decrease of at least 30% from baseline.
The target pressure range needs to be reassessed or changed as comparisons of  IOP  fluctuations, optic  nerve changes, and/or  visual  field  progression dictate.
Glaucoma medical therapy
Glaucoma surgery
Diabetic retinopathy medical therapy
Cataract surgery
Otosclerosis medical therapy
Dizziness medical therapy
Papilledema surgery
Dizziness surgery